Project Grant HT94252510058
Award Date
4/15/25
Completion Date
4/14/29
Dollars Obligated
$1.2M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Ann Arbor, MI 48109, USA
Similar Awards
The Defense Health Agency awarded a $1,178,939.00 Project Grant to the Regents of the University of Michigan under the Military Medical Research and Development program (CFDA 12.420) to conduct advanced phenotyping research to improve diagnostic, longitudinal assessment, and treatment strategies for deployment-related respiratory disease. The award period is from September 1, 2023 to August 31, 2026. As a U.S. Government Entity and top public research university, the University of Michigan has...
This $1,100,747 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, funds advanced biomedical research by the Regents of the University of Michigan to engineer antibody-drug conjugates. The goal is to coordinate the innate and adaptive immune systems for curative responses to diseases. This 3-year award, running from April 2025 to March 2028, supports cutting-edge research to transform healthcare for military service...
The Regents of the University of Michigan received a $312,000.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The 2-year grant, awarded on February 1, 2024, supports research to investigate "An Unexpected Role for the Ubiquitin Proteasome System in Repeat Associated Non-AUG Translation." This basic and translational biomedical research aims to advance understanding and treatment of neurological disorders...
This Project Grant award of $546,000.00 from the Defense Health Agency supports research at the Regents of the University of Michigan to develop a novel lectin for targeting T-cell lymphomas. The award is part of the Military Medical Research and Development program (CFDA 12.420), which funds basic, applied, and advanced biomedical research to transform healthcare for service members and the public through innovative and impactful research. The 3-year award began on September 1, 2023 and will...
The University of Michigan will receive $437,142 under a three-year Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420). The grant will fund research into ETV2 dysregulation in scleroderma endothelial cells from September 1, 2022 through August 31, 2025. The Military Medical Research and Development program supports biomedical research that transforms military and public health care through innovative solutions....
This $1,404,000.00 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program to the Regents of the University of Michigan, Office of Research and Sponsored Projects (doing business as the University of Michigan) on September 1, 2023. The funding will support research to target the lipid kinase PIKfyve in neuroendocrine prostate cancer over a 3-year period ending on August 31, 2026. The University of Michigan is a leading U.S....
This Project Grant from the Defense Health Agency provides $8,351,133 to the Regents of the University of Michigan from May 1, 2023 to April 30, 2027. The grant supports research under the Military Medical Research and Development program (CFDA 12.420) to investigate the pivotal and diverse roles of matricellular proteins in musculoskeletal disorders. The University of Michigan will conduct the primary research. Two subawards totaling $XXX,XXX were also issued to support complementary work....
The Defense Health Agency awarded a $607,377 Project Grant to the Regents of the University of Michigan to fund a 2-year research project titled "A NEW IDEA FOR ADVANCING AXITINIB-BASED THERAPY IN RECURRENT AND METASTATIC HNSCC." This grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform healthcare for service members and the public. The University of Michigan, a leading...
The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $467,742 Project Grant to the Regents of the University of Michigan to optimize a risk stratification model for ovarian cancer. The award will support research activities from September 1, 2024 through August 31, 2026. The University of Michigan, a top public research institution, has extensive experience conducting federal research and development projects for agencies such as the...
The University of Michigan was awarded a $624,000.00 Cooperative Agreement by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. This 2-year award, effective from September 15, 2024 to September 14, 2026, will support Phase 1/2 clinical trials assessment of new kidney cancer therapeutics. Through this project, the University of Michigan will leverage its expertise in cancer research, clinical trials, and therapeutics development...